Inside informationEnglish
Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 29/08/2025, 23:50
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 115409_20250829